Epigenomics Market Robust Expansion by Top Key Manufactures: Worldwide Overview by Size, Share, Trends, Segments
Fortune Business Insights foresees the pharmaceutical segment to dominate the global epigenomics market on account of the increasing prevalence of chronic diseases such as cancer. According to the World Health Organization (WHO), by the end of 2025, the number of cancer patients will reach 21,471,996.
View full press release